Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?

Expert opinion on therapeutic targets - 1 Oct 2009

Veltel Stefan, Wittinghofer Alfred

Abstract excerpt

Retinitis pigmentosa is the most important hereditary eye disease and there is currently no cure available. Although mutations were found in more than 40 genes in patients with retinitis pigmentosa, only two genes have thus far been found to be responsible for one of the most severe forms of the disease, X-linked retinitis pigmentosa. In this review, we highlight the current knowledge about the two gene products...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Eye Proteins
Share to Genetic Diseases, X-Linked
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to GTP-Binding Proteins

Share to Intracellular Signaling Peptides and Proteins

Share to Membrane Proteins

Share to Retinitis Pigmentosa

Source

Identifiers

PMID: 19702441
DOI: 10.1517/14728220903225016

Genes

RPGR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?PMID 19702441Read ↗

X-Linked Retinitis Pigmentosa Gene Therapy: Preclinical AspectsSemantic proximity Read ↗

Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa.Semantic proximity Read ↗

RPGR: part one of the X-linked retinitis pigmentosa story.Semantic proximity Read ↗

Novel variants of RPGR in X-linked retinitis pigmentosa families and genotype-phenotype correlation.Semantic proximity Read ↗

RPGR-Related Retinopathy: Clinical Features, Molecular Genetics, and Gene Replacement Therapy.Semantic proximity Read ↗

Retinitis Pigmentosa: Genes and Disease MechanismsSemantic proximity Read ↗

X-linked Retinitis Pigmentosa in Japan: Clinical and Genetic Findings in Male Patients and Female CarriersSemantic proximity Read ↗

Clinical and molecular findings in children with retinitis pigmentosa.Semantic proximity Read ↗

The first reported case of a deletion of the entire RPGR gene in a family with X-linked retinitis pigmentosa.Semantic proximity Read ↗

[Recent progress in molecular genetics and gene therapy for retinitis pigmentosa].Semantic proximity Read ↗

Disease mechanisms of X-linked retinitis pigmentosa due to RP2 and RPGR mutations.Semantic proximity Read ↗

The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: From Pathomolecular Mechanisms to the Development of Cell-Based TherapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.